APPLICATION OF LEECHES IN
TREATMENT OF MICROCIRCULATION DISTURBANCES IN RECONSTRUCTIVE AND HAND SURGERY
Paruzel Maciej, Jabłecki J., Domanasiewicz A., Elsaftawy A.
Subdepartment of Replantation
of Limbs St. Hedwig District Hospital in Trzebnica, Poland
Purpose: Possibilities of application of leeches in cases of disturbances of venal
out-flaw in replanted digits and insufficiency circulation in reconstructive
surgery cases.
Material and methods. The indication for treatment were venal out-flaw disturbances of different
etiology and their prophylaxis. Leeches were usually applied every 6-8 hours
(one-two leech on one finger), the duration of treatment was from 2 to 6 days
(4 days on average). After an effective application the animals were utilized.
The antibiotics of ciprofloxacin group were used as a prophylaxis of Aeromonas
hydrophilia’s infection.
Results. All of the fingers and skin flaps treated with leeches survived. A dramatic
improvement of local state of the fingers could be seen soon after the
application of leeches. All of the patients did not complain of any discomfort
associated with the therapy.
Conclusion. The application of leeches in cases of disturbances venal out – flaw in
replanted digits and insufficiency circulation skin flaps seems to be a
valuable alternative of other methods commonly used.
HIRUDOTHERAPY AND MAGGOT
DEBRIDEMENT THERAPY AS ALTERNATIVE MANAGEMENT OF A CHRONIC NONHEALING
ISCHEMIC WOUNDS
OUR EXPERIENCE IN
HIRUDOTHERAPY IN SLOVAKIA
Peter Takáč1,2, Mária
Habrmanová2, Henrieta Galátová1, Viliam Slezák1,3
1Scientica, s.r.o, Bratislava, Slovakia; 2Institute of
Zoology, Slovak Academy of Sciences, Bratislava, Slovakia; 3University
Hospital of the Merciful Brothers, Bratislava, Slovakia
Non healing chronic ischemic
wounds are a major clinical challenge very frequently encountered in the
clinical practice. Generally is known that in all kinds of non healing wounds
micro vascular angiopathy is one of the major factors for hypoxic condition,
leading to non-healing. Recently many new devices and techniques are evolved
for this purpose, but the efficacy in rectifying tiny micro vascular thrombus is
still a matter of discussion. Alternative treatment of wounds with leeches and
maggots , has approved very good results for healing different forms of wounds,
with great perspective in the standard use in practice.
It was found that leech
application improves the hypoxic condition, providing a moist environment for
wound healing, and that it helps in slough debridement in non healing ulcers
and most importantly leeches possess properties that
make them uniquely able to assist with venous compromised tissues.
At the same time the maggot
debridement therapy is a modern biotherapeutic method based on the use of
necrophagous flies to treat chronic non-healing wounds. In last two decades,
maggot debridement therapy became routinely used therapeutic method and thousands
of patients over the world had benefit of its healing power. Maggot
debridement therapy is a safe, reliable, cost-saving and very effective method
in management of chronic non-healing wounds. In our presentation we present the results of treatment with Hirudotherapy in
combination with Maggot debridement therapy. Alternative treatment of
wounds with leeches and maggots has approved very good results for healing
different forms of wounds, with great perspective in the standard use in
practice.
This work had been funded by
the Operational Program of Research and Development and co-financed with the
European Fund for Regional Development (EFRD). Grant: ITMS 26240220030:
Research and development of new biotherapeutic methods and its application in
some illnesses treatment.
CLINICAL LEECH THERAPY STUDIES IN WESTERN EUROPE
AND USA
Detlev Koeppen
Legal and financial restrictions constrain the performance of clinical
leech therapy studies with respect to the number of studies and their target
indications. In several European countries, leech therapy is hardly known or is
performed in legally not clearly defined areas. In USA, the use of leeching is
limited to rescue therapy measure in reconstructive surgery. The limited
financial resources of leech distributors do not allow the performance of
extensive clinical studies.
The existing studies focus on osteoarthritis, epicondylitis and venous
congestion.
Methodology and results of these studies are presented. Despite of the
limitations of clinical study performance in Western Europe and USA, the
existing results look encouraging and justify further preclinical and clinical
research.
LEECH
FARMING AT THE UNIVERSITY OF TEHRAN, PROSPECTIVE AND CHALLENGE
Masoumeh Malek
School of Biology and Center of Excellence in
Phylogeny of living organisms, College of Science, University of Tehran, Iran
DO SALIVARY PROTEINS
FROM HEMATOPHAGOUS LEECHES REACH PHARMACOLOGICALLY EFFECTIVE CONCENTRATIONS IN
THE HOST?
Sarah Lemke, Christian Müller,
Elisabeth Lipke, Gabriele Uhl, Jan-Peter Hildebrandt
Animal Physiology and
Biochemistry, Ernst Moritz Arndt-University
Saliva of hematophagous
leeches (Hirudo verbana) contains bioactive
substances which facilitate feeding and storage of ingested blood, but may also
exert beneficial effects in the host. As leeches transfer the entire mass of
stored salivary proteins into the host's wound during feeding, we determined
the resulting concentrations of salivary proteins in the circulatory system of
the host. We used serial sections (5 μm) of leech tissue from
the anterior body for 3D reconstruction of a block of leech tissue, determined
the mean volume of an individual gland cell (67,000 µm³) and the total number
of salivary gland cells present in one animal (37,000). Using protein staining
in homogenates of reference tissues and staining intensities of tissue sections
of reference as well as leech tissues, we determined the total mass of salivary
protein in one leech (average of 1.2 mg). Analyzing protein extracts of unfed
and fed leeches by 2D electrophoresis, we calculated the amounts of individual
salivary proteins which are transferred to the host during feeding. Assuming a
mean plasma volume in humans of 5 l, the maximally achievable molar
concentrations of salivary proteins in host plasma were calculated for 23
different proteins (3 - 236 pmol/l). As hirudin, the only salivary agent that
has been pharmacologicall
PHARMACY OF THE
MEDICINAL LEECH SALIVA IS THE SOURCE OF NOVEL NATURAL MULTIFUNCTIONAL DRUGS
Baskova I.P.
Biological Faculty of Moscow State
University, e-mail: saliva1@yandex.r
The medicinal leech
pharmacy is localized in salivary cells , which disseminated among the muscle
tissue of the anterior leech body. By using some methods of proteomic analysis
there were detected in secretion of salivary cells (SSC) more than 100 high
molecular weight (mol. 10 – 97 kDa) and about 150 low molecular weight (200-700
Da) substances (Baskova et al.., 2004, 2008). Now it is described more than 20
proteins and low molecular weight compounds of SSC. Their composition is
depended on the seasons and on the species of the medicinal leech (Hirudo verbana, H. medicinalis,
and H. orientalis). Among them there are the substances, which non synthesized in salivary
cells, but detected in their secretions. Mammalian blood, the important
component of the leech nutrition, is the sours of cholesterol, its derivatives
and of some steroid hormones. It is the way of medicinal leech adaptation to
feeding by blood of the warm-blooded animals.
Different methods of
proteomic analysis demonstrated the presence in the SSC of numerous unknown
substances of low- and high molecular weight. The medicinal leech Pharmacy is
full of the real biologically active components, which have been manifesting as
the humoral agents of hirudotherapy, effective method for treatment of the
diseases related to different divisions of medicine. Identification of the
medicinal leech pharmaceutical compounds would help to understand the
mechanisms of these treatment, but it will be possible only after the
discovering genome of this unique animal.
HIRUDOTHERAPY:
A UNIQUE METHOD IN TREATMENT OF THE CERTAIN EYE DISEASES
Tatiana Semyonovna Semikova, MD, PhD
The S.N. Fyodorov IRTC "Eye Microsurgery” (IRTC EM), Moscow
Purpose: To substantiate and extend indications for hirudotherapy application in ophthalmology. Medical leeches are traditionally used in treatment of acute glaucoma attacks and choroidal inflammations.
Materials and methods: An opportunity to extend the range of hirudotherapy application in treatment of various eye pathologies appeared basing on the mechanics of leech effect.
The medical effect of leeches is determined by their salivary glands properties: its secretion penetrates into human body when the leech bites through the coverlet and is incoming into the body during the whole period of bloodsucking. At that the secretion blocks the hemostatic thrombus formation in situ of the vascular wall damage realizing the optimal mechanisms of inhibition of platelet-vascula
Enzymes of the leech’s saliva possess the following properties: anticoagulative, antithrombotic, anti-inflammator
At the IRTC "Eye Microsurgery” leeches have found its application not only for glaucoma treatment both for arresting of the acute attack and for pre-op preparation. Hirudotherapy is widely used for elimination of the post-op complications, for macular edema diagnostics, inflammatory eye diseases treatment, iridocyclitis, chorioretinitis, dacryocystitis, sclerite, retrobulbar neuritis, hemorrhages of various etiology, endocrine ophthalmopathy, degenerative choroidal diseases, dry and wet forms of maculopathy, for acceleration of intraocular tumors resolution after brachytherapy, for elimination of complications related to radiation exposure.
Hirudotherapy creates practically no complications and side effects; it significantly decreases the period of recovery in inflammatory diseases; it makes the intraocular melanomas resolution period after brachytherapy 2-3 times shorter; it serves as a prevention of such post-op complications as secondary glaucoma and glaucoma-related pain syndrome, retinal detachment, hemorrhages into the vitreous body and retina. Leeches help to diagnose the macular edema and to treat it. Hirudotherapy can be conducted both in hospital and under outpatient conditions.
Conclusions: Hirudotherapy is a method of high efficiency for various eye pathologies treatment; it can be used both independently and in combination with the other methods in glaucoma, inflammatory, degenerative, tumor diseases and in ocular trauma.